About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Speaker: Marta Peris Sales, Research assistant. Neurotraumatology and Neurosurgery Research Unit (VHIR)
Abstract: Anemia affects up to 95% of neurocritical ICU patients within the first three days of admission. By reducing the blood’s oxygen-carrying capacity, anemia can significantly influence morbidity and mortality, especially in patients with critical illness or traumatic brain injury (TBI). Approximately 45% of these patients require at least five units of red blood cell concentrates (RBCs). The key challenge in managing anemia is striking a balance between ensuring adequate oxygen delivery to the brain and mitigating the risks associated with transfusions. Recent studies have raised concerns that alterations in stored RBCs may contribute to adverse outcomes. Our research aims to explore the effects of prolonged RBC storage, with a particular focus on changes in osmotic fragility and morphology. In this seminar, we will present the preliminary results of this study, highlighting the significant alterations observed in erythrocytes during blood bag storage.
Host: María Antonia Poca Pastor, Paediatric Neurosurgery, Children's Hospital and Woman's Hospital. Head of group Neurotraumatology and Neurosurgery Research Unit (UNINN)
Access here: https://gencat.zoom.us/j/94335255161
